Floatz logo

HUMAN FAECAL MATTER

Epilepsy

The Second Hospital of Nanjing Medical Universityother_biologicalPhase 2/3Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
73/ 100

Competitive context

77 Active assets in the Epilepsy cohort.

Asset / SponsorPhaseRating
Topamax
SK Life Science, Inc.
Phase 4BBB
Keppra
Beijing Tiantan Hospital
Phase 4BBB
Topamax
Université de Sherbrooke
Phase 4BBB
Lacosamide
Second Affiliated Hospital of Guangzhou Medical University
Phase 4BBB
Eslicarbazepine Acetate
Bial - Portela C S.A.
Phase 4BBB

View all 50 →

Same molecule, other indications

HUMAN FAECAL MATTER is also rated in:

cirrhosis of liverDormant
BB
Indicative ·
66 / 100
View asset →
hepatic encephalopathyDormant
B
Indicative ·
61 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →